PROMETHEUS BIOSCIENCES, INC. Deferred Revenue
PROMETHEUS BIOSCIENCES, INC. had Deferred Revenue of $16.96 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2023-02-28
- 2022-12-31: Deferred Revenue $16.96M.
- 2022-09-30: Deferred Revenue $17.18M.
- 2022-06-30: Deferred Revenue $17.51M.
- 2022-03-31: Deferred Revenue $17.93M.
| Period end | Deferred Revenue |
|---|---|
| 2022-12-31 | $16.96M 10-K · filed 2023-02-28 |
| 2022-09-30 | $17.18M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $17.51M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $17.93M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $19.87M 10-K · filed 2023-02-28 |
| 2021-09-30 | $15.31M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $15.73M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $6.07M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $6.47M 10-K · filed 2023-02-28 |
| 2019-12-31 | $1.54M 10-K · filed 2023-02-28 |